Shell Asset Management CO Acadia Pharmaceuticals Inc Transaction History
Shell Asset Management CO
- $2.29 Billion
- Q4 2024
A detailed history of Shell Asset Management CO transactions in Acadia Pharmaceuticals Inc stock. As of the latest transaction made, Shell Asset Management CO holds 6,530 shares of ACAD stock, worth $96,839. This represents 0.01% of its overall portfolio holdings.
Number of Shares
6,530
Previous 6,530
-0.0%
Holding current value
$96,839
Previous $100,000
20.0%
% of portfolio
0.01%
Previous 0.0%
Shares
27 transactions
Others Institutions Holding ACAD
# of Institutions
327Shares Held
166MCall Options Held
855KPut Options Held
350K-
Baker Bros. Advisors LP New York, NY42.9MShares$636 Million8.72% of portfolio
-
Vanguard Group Inc Valley Forge, PA13.9MShares$207 Million0.0% of portfolio
-
Black Rock Inc. New York, NY12.1MShares$179 Million0.0% of portfolio
-
Rtw Investments, LP New York, NY8.71MShares$129 Million2.61% of portfolio
-
Morgan Stanley New York, NY7.3MShares$108 Million0.01% of portfolio
About ACADIA PHARMACEUTICALS INC
- Ticker ACAD
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 161,843,008
- Market Cap $2.4B
- Description
- ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders. The company offers NUPLAZID (pimavanserin) for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. It's p...